Skip to content
Austin Top 50
Author:
Notorious Design Group (NDG)
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
August 20, 2026
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
July 29, 2026
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
June 29, 2026
Notorious Design Group Announces Upcoming Release of Graffiti Artist Trading Card Collection Drop 2
May 16, 2026